Literature DB >> 28916176

Risk stratification of sudden cardiac death in hypertension.

Larisa G Tereshchenko1, Elsayed Z Soliman2, Barry R Davis3, Suzanne Oparil4.   

Abstract

In the United States, up to 450,000 people per year die suddenly; an average of 1 sudden death every 70s. Strategies for preventing sudden cardiac death are urgently needed. Systemic arterial hypertension is a major risk factor for sudden cardiac death and the increasing burden of hypertension is a worldwide problem. The lifetime risk of sudden cardiac death at 30years of age is higher by 30% in individuals with hypertension. Each 20/10mmHg increase in systolic/diastolic blood pressure, is associated with a 20% additional increase in sudden cardiac death risk. Theoretically, antihypertensive treatment should be an effective strategy for sudden cardiac death prevention. However, a recent meta-analysis of 15 randomized controlled trials showed that antihypertensive treatment does not reduce the incidence of sudden cardiac death. This manuscript reviews ECG predictors of sudden cardiac death and the importance of risk stratification for appropriate management of hypertension.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Global electrical heterogeneity; Hypertension; Sudden cardiac death

Mesh:

Year:  2017        PMID: 28916176      PMCID: PMC5724934          DOI: 10.1016/j.jelectrocard.2017.08.012

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  55 in total

Review 1.  A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.

Authors:  Arnfried U Klingbeil; Markus Schneider; Peter Martus; Franz H Messerli; Roland E Schmieder
Journal:  Am J Med       Date:  2003-07       Impact factor: 4.965

2.  Diagnostic and prognostic utility of electrocardiography for left ventricular hypertrophy defined by magnetic resonance imaging in relationship to ethnicity: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Aditya Jain; Harikrishna Tandri; Darshan Dalal; Harjit Chahal; Elsayed Z Soliman; Ronald J Prineas; Aaron R Folsom; João A C Lima; David A Bluemke
Journal:  Am Heart J       Date:  2010-04       Impact factor: 4.749

3.  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

Authors: 
Journal:  JAMA       Date:  1967-12-11       Impact factor: 56.272

4.  Systematic review of the incidence of sudden cardiac death in the United States.

Authors:  Melissa H Kong; Gregg C Fonarow; Eric D Peterson; Anne B Curtis; Adrian F Hernandez; Gillian D Sanders; Kevin L Thomas; David L Hayes; Sana M Al-Khatib
Journal:  J Am Coll Cardiol       Date:  2011-02-15       Impact factor: 24.094

5.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

6.  Distinct cellular and molecular mechanisms underlie functional remodeling of repolarizing K+ currents with left ventricular hypertrophy.

Authors:  Céline Marionneau; Sylvain Brunet; Thomas P Flagg; Thomas K Pilgram; Sophie Demolombe; Jeanne M Nerbonne
Journal:  Circ Res       Date:  2008-05-01       Impact factor: 17.367

7.  Electrocardiographic Left Ventricular Hypertrophy as a Predictor of Cardiovascular Disease Independent of Left Ventricular Anatomy in Subjects Aged ≥65 Years.

Authors:  J Adam Leigh; Wesley T O'Neal; Elsayed Z Soliman
Journal:  Am J Cardiol       Date:  2016-03-19       Impact factor: 2.778

Review 8.  Blood pressure, systolic and diastolic, and cardiovascular risks. US population data.

Authors:  J Stamler; R Stamler; J D Neaton
Journal:  Arch Intern Med       Date:  1993-03-08

Review 9.  Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.

Authors:  K T Weber; C G Brilla
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

Review 10.  Cardiac Hypertrophy: An Introduction to Molecular and Cellular Basis.

Authors:  Mostafa Samak; Javid Fatullayev; Anton Sabashnikov; Mohamed Zeriouh; Bastian Schmack; Mina Farag; Aron-Frederik Popov; Pascal M Dohmen; Yeong-Hoon Choi; Thorsten Wahlers; Alexander Weymann
Journal:  Med Sci Monit Basic Res       Date:  2016-07-23
View more
  2 in total

Review 1.  Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk.

Authors:  Goran Koracevic; Milovan Stojanovic; Dragan Lovic; Marija Zdravkovic; Dejan Sakac
Journal:  J Hum Hypertens       Date:  2021-03-02       Impact factor: 3.012

Review 2.  Antihypertensive therapy and sudden cardiac death, should we expect the unexpected?

Authors:  Elias Sanidas; Konstantinos Malliaras; Dimitrios Papadopoulos; Maria Velliou; Konstantinos Tsakalis; Kanella Zerva; John Barbetseas
Journal:  J Hum Hypertens       Date:  2020-01-14       Impact factor: 3.012

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.